Federal judge rejects Takeda’s tactic in generics patent brawl


District Judge Lucy Koh of the Northern District of California has cried foul over punches thrown by Takeda Pharmaceutical Co. in a patent brawl to decide the fate of a planned generic for its acid reflux drug. Judge Koh rejected Takeda’s claims for declaratory judgment that Mylan Inc. will infringe its patents when it begins making a generic for Takeda’s Dexilant drug. Koh wrote that Takeda’s bid for declaratory judgment was overkill in light of other claims it had filed against Mylan under the Hatch-Waxman Act, which governs patent spats over generic drugs.

Read the source article at The Recorder

About the Author

Leave a Reply